Eun-Seok Kim

Director Ejecutivo en DAE HWA PHARMACEUTICAL CO., LTD. .

Fortuna: 3 M $ al 31/05/2024

48 años

Health Technology

Consumer Services

Perfil

Eun-Seok Kim is currently the President, Co-Chief Executive Officer & Director at DAE HWA PHARM Co., Ltd.
and a Director at RedoxBio Co., Ltd.
He has a background in undergraduate and graduate studies from Sungkyunkwan University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea. 2.52%	31/03/2023	621 300 ( 2.52% )	1 M $	31/12/2020
DAE HWA PHARM CO., LTD. 1.05%	05/04/2024	195 000 ( 1.05% )	1 M $	31/05/2024

Cargos activos de Eun-Seok Kim

Empresas	Cargo	Inicio
DAE HWA PHARMACEUTICAL CO., LTD.	Director Ejecutivo	20/03/2015
RedoxBio Co., Ltd. RedoxBio Co., Ltd. Pharmaceuticals: MajorHealth Technology RedoxBio Co., Ltd. engages in the manufacture and sale of materials for pharmaceutical products. It operates through Hyaluronic Acid and Chemical business divisions. Its products include hyaluronic filler, methylol cephalexin lysinate, sodium hyaluronate, and others. The company was founded on August 26, 2010 and is headquartered in Hwaseong-si, South Korea.	Director/Miembro de la Junta	-